Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 46

Sort by

Sort Order Select

Journal Articles

EBNA2: a viral maestra conducting a symphony orchestra

Maher K. Gandhi, Gemma L. Kelly

Blood (2024) 143 (5): 384–385.

https://doi.org/10.1182/blood.2023022744

Published: 2024

Journal Articles

EBV-infected hematopoietic stem cells drive CAEBV

Rajiv Khanna, Maher K. Gandhi

Blood (2024) 143 (1): 2–4.

https://doi.org/10.1182/blood.2023022739

Published: 2024

Journal Articles

High Frequency of HLA-Class II B Cell Receptor Neoantigens in IGHV Mutated-CLL

Muhammed B. Sabdia, Melinda Burgess, Soi Cheng Law, Lauren A Thurgood, Stephen Kazakoff, Fiona Swain, Joshua W.D. Tobin, Peter Mollee, Ann-Marie Patch, Maher K Gandhi

Blood (2023) 142 (Supplement 1): 3260.

https://doi.org/10.1182/blood-2023-174149

Published: 2023

Journal Articles

Genome-wide transcription factor–binding maps reveal cell-specific changes in the regulatory architecture of human HSPCs

Blood (2023) 142 (17): 1448–1462.

https://doi.org/10.1182/blood.2023021120

Published: 2023

Includes: Supplemental data

Journal Articles

Genetic susceptibility to EBV-related disease

Maher K. Gandhi

Blood (2023) 141 (13): 1499–1500.

https://doi.org/10.1182/blood.2022019180

Published: 2023

Journal Articles

Comparative Analysis of Genome-Scale Gene Regulatory Networks in Human Hematopoietic Stem and Myeloid Progenitor Fractions

Blood (2022) 140 (Supplement 1): 2846–2848.

https://doi.org/10.1182/blood-2022-165620

Published: 2022

Journal Articles

Identification of Genetic Subtypes in Follicular Lymphoma

Blood (2022) 140 (Supplement 1): 6371–6373.

https://doi.org/10.1182/blood-2022-164610

Published: 2022

Journal Articles

Discordant solutions to discordant problems

Joshua W. D. Tobin, Maher K. Gandhi

Blood (2021) 137 (21): 2857–2858.

https://doi.org/10.1182/blood.2021011362

Published: 2021

Journal Articles

Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment

Takumi Kobayashi, Pui Yeng Lam, Hui Jiang, Karolina Bednarska, Renee Gloury, Valentine Murigneux, Joshua Tay, Nicolas Jacquelot, Rui Li, Zewen Kelvin Tuong, Graham R. Leggatt, Maher K. Gandhi, Michelle M. Hill, Gabrielle T. Belz, Shyuan Ngo, Axel Kallies, Stephen R. Mattarollo

Blood (2020) 136 (26): 3004–3017.

https://doi.org/10.1182/blood.2020005602

Published: 2020

Includes: Supplemental data

Journal Articles

The Genetic Landscape in Elderly DLBCL Aged > 75 Years in the Australasian Leukaemia & Lymphoma Group NHL29 Iric Trial Identifies New Targetable Mutations

Sewa Rijal, Jun Hee Lim, PhD, Lillian Smyth, Caitlin Coombes, MChD, Sanjiv Jain, MBBS, Kartik Saxena, PhD, Judith Trotman, FRACP, Emma Verner, MBBS, FRACP, FRCPA, Maher K. Gandhi, PhDFRACP,FRCPath, Kaushal Gandhi, PhD, Dipti Talaulikar, PhD FRACP, FRCPA, MBBS

Blood (2020) 136 (Supplement 1): 18–20.

https://doi.org/10.1182/blood-2020-141795

Published: 2020

Journal Articles

Neoantigens Are Typically Associated with Intact HLA Class I Presentation in Early-Stage Follicular Lymphoma

Hennes Tsang, BSc, Ann-Marie Patch, PhD, Colm Keane, MD, Soi C. Law, PhD, Jay Gunawardana, PhD, Piers Blombery, MBBS, Ella R Thompson, PhD BSc, Muhammed B. Sabdia, Lilia Merida De Long, Clemence J Belle, Karthik Nath, MBBS, Joshua W.D. Tobin, MD, Stephen H Kazakoff, PhD, John F. Seymour, Michael MacManus, Maher K. Gandhi, PhDFRACP,FRCPath

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-135954

Published: 2020

Journal Articles

A Cost-Effectiveness Analysis of Front-Line Treatment Strategies in Early Stage Follicular Lymphoma

Joshua W.D. Tobin, MD, Greg Hapgood, BMBS, FRACP, FRCPA, Maher K. Gandhi, PhDFRACP,FRCPath, Peter Mollee, FRACP,MBBS,MSc,FRCPA, Ti Ma, BSci, Anna Crothers, Paul Scuffham

Blood (2020) 136 (Supplement 1): 54–55.

https://doi.org/10.1182/blood-2020-138590

Published: 2020

Journal Articles

EBV microRNA-BHRF1-2-5p targets the 3′UTR of immune checkpoint ligands PD-L1 and PD-L2

Alexandre S. Cristino, Jamie Nourse, Rachael A. West, Muhammed Bilal Sabdia, Soi C. Law, Jay Gunawardana, Frank Vari, Sally Mujaj, Gayathri Thillaiyampalam, Cameron Snell, Madeline Gough, Colm Keane, Maher K. Gandhi

Blood (2019) 134 (25): 2261–2270.

https://doi.org/10.1182/blood.2019000889

Published: 2019

Includes: Supplemental data

Journal Articles

Outcomes for Patients with Primary or Secondary Central System Lymphoma Treated with Ibrutinib: A Multicentre Retrospective Analysis

Katharine L Lewis, FRCPath, MRCP, MBBS, Kate Manos, MBBS, John Casey, FRACP,FRCPA,MBBS, Julie Crawford, MDMBBS,FRACP, Shir-Jing Ho, FRACP,FRCPA,MBBS, Samar Issa, FRACP, Andrew Grigg, Peter Wood, Maher K. Gandhi, PhD, Eliza A Hawkes, Chan Y. Cheah

Blood (2019) 134 (Supplement_1): 1620.

https://doi.org/10.1182/blood-2019-125730

Published: 2019

Journal Articles

Interim Circulating Tumor DNA As a Prognostic Biomarker in the Setting of Interim PET-Based Adaptive Therapy for DLBCL

Charles Macaulay, MSc, BA, Stefan Alig, MD, David M. Kurtz, MD PhD, Michael C. Jin, BS, Stephen Opat, Joanne Soo, MD, Brian Sworder, MD PhD, Mark S. Hertzberg, MD PhD, Maher K. Gandhi, PhD, Maximilian Diehn, MD PhD, Ash A. Alizadeh, MD PhD

Blood (2019) 134 (Supplement_1): 1600.

https://doi.org/10.1182/blood-2019-131278

Published: 2019

Journal Articles

A Complicated Neighborhood: Insights into the Hodgkin Lymphoma Microenvironment

Maher K. Gandhi, PhD

Blood (2019) 134 (Supplement_1): SCI-8.

https://doi.org/10.1182/blood-2019-121284

Published: 2019

Journal Articles

Intra-Tumoral CD8+ T-Cells in Follicular Lymphoma Contain Large Clonal Expansions That Are Amenable to Dual-Checkpoint Blockade

Karthik Nath, MBBS, Soi C. Law, Muhammed B. Sabdia, Lilia Merida De Long, Mohamed Shanavas, MD, Joshua W.D. Tobin, MD, Jay Gunawardana, PhD, Frank Vari, PhD, Sarah-Jane Halliday, Annette Hernandez, BS, Donna Cross, Robert J. Bird, FRACP,FRCP,FRCPA,MBBS,MRCP, Colm Keane, MD, Maher K. Gandhi, PhD

Blood (2019) 134 (Supplement_1): 2793.

https://doi.org/10.1182/blood-2019-130050

Published: 2019

Journal Articles

The IRE1-XBP1s Pathway Impairment Underpins NK Cell Dysfunction in Hodgkin Lymphoma, That Is Partly Restored By PD-1 Blockade

Karolina Bednarska, Jay Gunawardana, PhD, Frank Vari, PhD, Qingyan Cui, PhD, Gayathri Thillaiyampalam, MSc, BSc, Samantha Stehbens, PhD, Sally Mujaj, PhD, Jamie Nourse, PhD, Alexandre Cristino, PhD, Maher K. Gandhi, PhD

Blood (2019) 134 (Supplement_1): 2795.

https://doi.org/10.1182/blood-2019-126372

Published: 2019

Journal Articles

B2M Gene Expression Reflects an Immunologically Active Tumor Microenvironment in DLBCL

Clare Gould, Colm Keane, MD, Valentine Murigneux, M.Sc., Harald Oey, Jonathan Ellis, PhD, Simone Birch, MBBS, Jay Gunawardana, PhD, Dipti Talaulikar, Mark S. Hertzberg, MD PhD, Kimberley Jones, Maher K. Gandhi, PhD

Blood (2019) 134 (Supplement_1): 2778.

https://doi.org/10.1182/blood-2019-126537

Published: 2019

Journal Articles

The Tumor Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma Is a Unique Immunobiological Entity Distinct from Classical Hodgkin Lymphoma

Jay Gunawardana, PhD, Karolina Bednarska, M.Sc., Soi C Law, PhD, Justina Lee, B.Sc. (Hon)., Muhammed Bilal Sabdia, BSc(Hons), Joshua W.D. Tobin, MD, Simone Birch, MBBS, Colm Keane, MB BCh BAO PhD MBA, Maher K Gandhi, PhD

Blood (2018) 132 (Supplement 1): 4123.

https://doi.org/10.1182/blood-2018-99-115836

Published: 2018

NARROW

EBNA2: a viral maestra conducting a symphony orchestra

EBV-infected hematopoietic stem cells drive CAEBV

High Frequency of HLA-Class II B Cell Receptor Neoantigens in IGHV Mutated-CLL

Genome-wide transcription factor–binding maps reveal cell-specific changes in the regulatory architecture of human HSPCs

Genetic susceptibility to EBV-related disease

Comparative Analysis of Genome-Scale Gene Regulatory Networks in Human Hematopoietic Stem and Myeloid Progenitor Fractions

Identification of Genetic Subtypes in Follicular Lymphoma

Discordant solutions to discordant problems

Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment

The Genetic Landscape in Elderly DLBCL Aged > 75 Years in the Australasian Leukaemia & Lymphoma Group NHL29 Iric Trial Identifies New Targetable Mutations

Neoantigens Are Typically Associated with Intact HLA Class I Presentation in Early-Stage Follicular Lymphoma

A Cost-Effectiveness Analysis of Front-Line Treatment Strategies in Early Stage Follicular Lymphoma

EBV microRNA-BHRF1-2-5p targets the 3′UTR of immune checkpoint ligands PD-L1 and PD-L2

Outcomes for Patients with Primary or Secondary Central System Lymphoma Treated with Ibrutinib: A Multicentre Retrospective Analysis

Interim Circulating Tumor DNA As a Prognostic Biomarker in the Setting of Interim PET-Based Adaptive Therapy for DLBCL

A Complicated Neighborhood: Insights into the Hodgkin Lymphoma Microenvironment

Intra-Tumoral CD8+ T-Cells in Follicular Lymphoma Contain Large Clonal Expansions That Are Amenable to Dual-Checkpoint Blockade

The IRE1-XBP1s Pathway Impairment Underpins NK Cell Dysfunction in Hodgkin Lymphoma, That Is Partly Restored By PD-1 Blockade

B2M Gene Expression Reflects an Immunologically Active Tumor Microenvironment in DLBCL

The Tumor Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma Is a Unique Immunobiological Entity Distinct from Classical Hodgkin Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only